Gregory A. Abel

Assistant Professor
Hematologic Oncology 
Dana-Farber Cancer Institute
United States of America

Physician Oncology
Biography

 Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.

Research Intrest

Leukemia, Myelodysplastic syndromes, Myeloproliferative disorders

List of Publications
Abel, G. A., Chen, K., Taback, N., Hassett, M. J., Schrag, D., & Weeks, J. C. (2013). Impact of oncology‐related direct‐to‐consumer advertising. Cancer, 119(5), 1065-1072.
Abel, G. A., Neufeld, E. J., Sorel, M., & Weeks, J. C. (2008). Direct‐to‐consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims. Journal of Thrombosis and Haemostasis, 6(10), 1680-1684.
Kumar, A., Vanderplas, A., LaCasce, A. S., Rodriguez, M. A., Crosby, A. L., Lepisto, E., ... & Millenson, M. (2012). Lack of benefit of central nervous system prophylaxis for diffuse large B‐cell lymphoma in the rituximab era. Cancer, 118(11), 2944-2951.